ColigoMed is a next-generation digital health company that provides an AI-powered integrated care platform designed for value-based healthcare. Founded in 2021, the company leverages generative AI, Large Language Models (LLMs), and blockchain technology to bridge gaps in the healthcare system by connecting patients, caregivers, providers, and payers through full data interoperability. The company’s platform focuses on automating complex clinical workflows, such as prior authorizations and transition-of-care documentation, while facilitating at-home care programs. By integrating with major Electronic Health Record (EHR) systems and remote monitoring devices, ColigoMed enables proactive management of chronic conditions and aims to reduce hospital readmissions and improve long-term clinical outcomes.
CLASSIFICATION
Company Type:Digital Health
Industry:Digital Health
Sub-Industry:AI Healthcare Platforms
SIZE & FINANCIALS
Employees:11-50
Revenue:$1M-$5M
Founded:2021
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$8M
Investors:InnovatorMD, Practicing physicians and medical specialists, Healthcare technology executives
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (SaaS Platform)
Modalities:Generative AI, Remote Patient Monitoring (RPM), Chronic Care Management (CCM), Agentic AI, Blockchain
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Integrated with major EHR vendors representing 80% market share (Epic, Oracle Health/Cerner, Meditech), NextGrowthX (Brand and digital presence partner)
COMPETITION
Position:Emerging
Competitors:Akido Labs, HealthVerity, OMNY, Huma, Teladoc Health, Mahalo Health
LEADERSHIP
Key Executives:
Naidu Annamaneni - Founder & CEO
Dr. Ramarao Lankipalli - Co-founder & CMO
Srividya Sunderamurthy - Co-founder & CPO
Scientific Founders:Naidu Annamaneni, Dr. Ramarao Lankipalli
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with ColigoMed. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.